OCT 16, 2018 08:22 PM PDT

Immunotherapeutic Targets A Blood-Clotting Protein

WRITTEN BY: Nouran Amin

Fibrin is a blood protein that normally does not cross to the brain, however, several neurological disorders have a defect in the blood-brain barrier that allow large molecules, like fibrin, to pass through triggering inflammation. Many studies have pointed to a leaky blood-brain barrier as an early event in brain diseases that causes neurodegeneration. The process is believed to be implicated in the death of nerve cells seen in multiple sclerosis, Alzheimer's disease, and other disorders.

Treatments intended to inhibit the blood from harming the brain have not been available due to researchers fear of targeting the blood-clotting protein, fibrin, and the effect it may hold on bleeding patients. But, now, researchers from the Gladstone Institutes have found a way to overcome this hurdle with a new immunotherapy; a highly effective antibody that inhibits the biochemical activity of fibrin that contributes to neurodegeneration in the brain

"We have developed a monoclonal antibody to target a major culprit in the blood that damages the brain," said Katerina Akassoglou, PhD, lead investigator and a professor in the Department of Neurology at UC San Francisco. "Fibrin-targeting immunotherapy could protect the brain from the toxic effects of blood leakage and may also have beneficial effects in other organs affected by inflammatory conditions with vascular damage."

In a mouse model, the new antibody would enter the brain and accumulate in fibrin-rich regions, protecting against neuro-inflammation and neurodegeneration in both disease models. The research team published their findings in Nature Immunology. "We discovered that fibrin also contributes to brain disease through oxidative stress -- an unanticipated result," says research scientist and first author of the study, Jae Kyu Ryu, PhD. "Treatment with the antibody put a damper on this fibrin-driven oxidative mechanism, which may contribute to many different neurodegenerative diseases."

Chemical Structure of Fibrin. Image via NIH

The study treated mouse models of Alzheimer’s with the antibody after they had developed an accumulation of amyloid proteins in their brain; a hallmark of the disease. In comparison, to the placebo, the mice had less brain inflammation and less neuronal death. "Our study supports that vascular damage leading to immune-driven neurodegeneration may be a common thread between diseases of different etiologies with blood-brain barrier leaks," said Akassoglou. "Targeting fibrin with immunotherapy is a new approach that could be used to test the therapeutic benefits of suppressing this pathogenic mechanism in multiple disease contexts."

Source: Gladstone Institute

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 11, 2018
Drug Discovery
SEP 11, 2018
Widely-Used Drug Contributed To Skin Cancer
In a research study at the University of Dundee, Queen Mary University of London and the Wellcome Sanger Institute, a drug, by the name of azathioprine, wh...
SEP 15, 2018
Videos
SEP 15, 2018
A Hangover Cure in a Pill
A night of drinking can lead to a morning of regret for many people, but science is working on a solution for the physical pain....
NOV 15, 2018
Drug Discovery
NOV 15, 2018
A Subclass of Anti-Aging Compounds Serves as Alzheimer's Drug Candidates
In a publication in Trends in Pharmacological Sciences, a subclass of anti-aging compounds, called geroneuroprotectors (GNPs), have been identified in rese...
DEC 11, 2018
Cancer
DEC 11, 2018
FDA approves two new drugs for cancers with specific genetic mutations
Last month the FDA approved two new drugs for cancer, both drugs target cancers with specific genetic mutations which made geneticists and oncologists optimistic on the future of cancer thera...
DEC 18, 2018
Drug Discovery
DEC 18, 2018
Increasing Misuse of Prescription Drugs
According to a study published in Psychiatric Services in Advance, misuse of prescription drugs accounts for more than 17 percent of overall use. In the st...
JAN 15, 2019
Immunology
JAN 15, 2019
A Possible Key to Severe Flu
By studying the impact that NPY and its receptor Y1R have on influenza in mice, the research group has now discovered that NPY produced in lung phagocytes can aggravate influenza....
Loading Comments...